McDonald's (MCD)
(Delayed Data from NYSE)
$289.52 USD
+0.31 (0.11%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $289.54 +0.02 (0.01%) 7:58 PM ET
5-Strong Sell of 5 5
F Value D Growth C Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$289.52 USD
+0.31 (0.11%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $289.54 +0.02 (0.01%) 7:58 PM ET
5-Strong Sell of 5 5
F Value D Growth C Momentum F VGM
Zacks News
Red Robin (RRGB) Q2 Earnings Lag Estimates, Revenues Beat
by Zacks Equity Research
Red Robin's (RRGB) second-quarter fiscal 2024 results are negatively impacted by the broader industry slowdown.
McDonald's Corporation (MCD) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching McDonald's (MCD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks Investment Ideas feature highlights: Viking Therapeutics, McDonalds, Starbucks, Novo Nordisk and Eli Lilly
by Zacks Equity Research
Viking Therapeutics, McDonalds, Starbucks, Novo Nordisk and Eli Lilly have been highlighted in this Investment Ideas article.
Massive Weight Loss Market: Viking (VKTX) is Best-in-Breed
by Andrew Rocco
Viking Therapeutics (VKTX) has developed a best-in-breed GLP-1 drug. The company is poised to gain a large portion of the massive weight loss drug market.
CAVA Group (CAVA) to Post Q2 Earnings: Buy, Sell or Wait?
by Harendra Ray
CAVA Group's (CAVA) second-quarter 2024 top line is likely to have been aided by an increase in visitation and menu price.
Bull of the Day: ServiceNow (NOW)
by Andrew Rocco
Workday, a software enterprise leader, is poised to benefit from work-from-home and automation trends in the software industry. Moreover, the company should benefit handsomely from a "dovish" Federal Reserve."
Brokers Suggest Investing in McDonald's (MCD): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in McDonald's (MCD). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Shake Shack (SHAK) Rides on Expansion Efforts, High Costs Ail
by Zacks Equity Research
Shake Shack (SHAK) benefits from robust same-shack sales, strategic expansion and innovative menu offerings.
McDonald's (MCD) Q2 Results Review: Time to Buy or Red Flag?
by Harendra Ray
McDonald's (MCD) is hurt by dismal comps performance and high costs. The company's comps fall for the first time after increasing in 13 straight quarters.
Wall Street Bulls Look Optimistic About McDonald's (MCD): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for McDonald's (MCD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
The Zacks Analyst Blog Highlights Walmart, McDonald's, Booking Holdings and Oil-Dri
by Zacks Equity Research
Walmart, McDonald's, Booking Holdings and Oil-Dri are part of the Zacks top Analyst Blog.
McDonald's Corporation (MCD) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching McDonald's (MCD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Shake Shack (SHAK) Q2 Earnings Meet Estimates, Revenues Top
by Zacks Equity Research
Shake Shack's (SHAK) fiscal second-quarter performance reflects benefits from product innovations, strategic menu pricing, technology implementations and promotions.
Wendy's (WEN) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Wendy's (WEN) second-quarter fiscal 2024 results benefit from solid same-restaurant sales, strength in U.S. breakfast sales and digital sales momentum.
Beacon (BECN) Q2 Earnings & Sales Miss Estimates, Shares Down
by Zacks Equity Research
Solid demand, higher pricing and recent acquisitions drive Beacon Roofing's (BECN) second-quarter results.
Top Analyst Reports for Walmart, McDonald's & Booking Holdings
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc. (WMT), McDonald's Corporation (MCD) and Booking Holdings Inc. (BKNG), as well a micro-cap stock Oil-Dri Corporation of America (ODC).
Cheesecake Factory (CAKE) Q2 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Cheesecake Factory's (CAKE) fiscal second-quarter performance benefits from strong consumer demand and new restaurant openings.
Market Awaits JOLTS Numbers Due Tuesday
by Zacks Equity Research
Market Awaits JOLTS Numbers Due Tuesday.
McDonald's (MCD) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
McDonald's (MCD) second-quarter U.S. comps have been hurt by the decline in guest counts, though this has been somewhat balanced by higher average checks thanks to strategic menu price increases.
Big Numbers Ahead: Q2 Earnings, Fed Meeting, Jobs Week
by Mark Vickery
Jobs Week, Fed Week and the busiest week of Q2 earnings so far await us.
Here's What Key Metrics Tell Us About McDonald's (MCD) Q2 Earnings
by Zacks Equity Research
The headline numbers for McDonald's (MCD) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
McDonald's (MCD) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
McDonald's (MCD) delivered earnings and revenue surprises of -3.57% and 2.42%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Starbucks (SBUX) Q3 Earnings Loom: Buy, Sell or a Wait-and-See?
by Harendra Ray
Starbucks' (SBUX) third-quarter fiscal 2024 performance is likely to have been hurt by slower-than-anticipated recovery in China.
Unlocking Q2 Potential of McDonald's (MCD): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for McDonald's (MCD), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.
How to Play McDonald's (MCD) Ahead of Q2 Earnings Release?
by Harendra Ray
McDonald's (MCD) second-quarter 2024 performance is likely to have been aided by strong digital adoption, innovative menu additions and strategic unit expansion.